Current status: 1050 hESC lines, 6624 hiPSC lines, and 158 clinical studies, and 2344 certificates
Monthly statistic from Nov 1, 2024
Posted on November 1, 2024
total lines | 7674 |
hESC lines | 1050 |
hiPSC lines | 6624 |
derivation countries | 50 |
projects | 310 |
providers | 940 |
clinical studies | 158 |
subclones | 3193 |
certificates | 2344 |
cell line certificates | 2198 |
project certificates | 146 |